Sara Motka: We Create Greater Synergies Between Haemophilia and Haemoglobinopathies
Sara Motka, Head of Programmes at the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, reposted from Novo Nordisk Haemophilia and Haemoglobinopathies Foundation on LinkedIn:
”Thrilled to announce the expansion of NNHF! We will amplify our efforts in data-driven advocacy, forge stronger partnerships, and create greater synergies between haemophilia and haemoglobinopathies. Our mission goes beyond connecting and building opportunities for the global bleeding disorders community; we will aim to make a meaningful contribution to sickle cell disease and thalassaemia too. We will continue to connect, enable, and accelerate. Impacting care – Together!”
Qutoing Novo Nordisk Haemophilia and Haemoglobinopathies Foundation‘s post:
”We are now the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation!
Proudly, we are unveiling our Foundation’s new chapter:
We are expanding our support beyond people with haemophilia to people with sickle cell disease and thalassaemia as well.
Building on two decades of work in haemophilia, and enabled by a renewed partnership with the Novo Nordisk Foundation and the continued funding from our founder Novo Nordisk, we are expanding our scope to include haemoglobinopathies. We will apply our proven, partnership-led model to develop tailored programmes that benefit people with haemophilia and haemoglobinopathies, their healthcare professionals, and families – always adapted to local needs.
Let us tell you more here.
Ludovic Helfgott, Mads Krogsgaard Thomsen, Maziar Mike Doustdar, Amy Shapiro, Stephanie Seremetis, Johnny Mahlangu, Ognenka Kozar, Denise B., Amos Gitonga M, Llyord Mwaniki, Célia Rohrer, Gatoto Carole, Sara Motka, Xio Fong Vilaysane, Elisa Eleftheriou, Natasha Honan.”
Stay updated with Hemostasis Today.
-
Jun 11, 2026, 07:06Bernard Slater Jr.: Hemophilia B Reminds You that No Matter How Strong You Are, You Are Still Human
-
Jun 11, 2026, 05:11Daniel I McIsaac: Less Blood Loss and No Excess VTE with Tranexamic Acid in High-Risk Surgery
-
Jun 11, 2026, 05:03Aymeric Couturier: Lessons from the TRACK Trial on Anticoagulation in Advanced CKD
-
Jun 11, 2026, 04:53Umut Kocabas: Current Practice and Guideline Adherence on Cancer-Associated Thrombosis in Turkey
-
Jun 11, 2026, 04:40Fernanda Orsi: Which Obstetric APS Patients Are More Likely to Develop Thromboses?
-
Jun 10, 2026, 18:22Winai Porntipworawech: The $50 Life-Saving Drug Big Pharma Doesn’t Want You to See
-
Jun 10, 2026, 18:09Leonard Valentino: Innovation in Blood Disorders Being Catalyzed by Pathway to Cures
-
Jun 10, 2026, 18:00Smitirupa Mishra: Normal Hemoglobin Does Not Always Mean Normal Genes
-
Jun 10, 2026, 17:58Talat Uppal: Addressing HMB with RACGP’s Dr. Ramya Raman